P1653: CLINICAL EFFICACY AND SAFETY OF SWITCHING ELTROMBOPAG AND RH-TPO IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA DURING THE COVID-19 PANDEMIC
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000849468.68112.e2 |
| _version_ | 1827336995142107136 |
|---|---|
| author | X. Cai X.-H. Zhang |
| author_facet | X. Cai X.-H. Zhang |
| author_sort | X. Cai |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:43:29Z |
| format | Article |
| id | doaj.art-69716bf1b8014eca86409392f0c6e302 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:43:29Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-69716bf1b8014eca86409392f0c6e3022024-03-02T03:29:08ZengWileyHemaSphere2572-92412022-06-0161534153510.1097/01.HS9.0000849468.68112.e2202206003-01534P1653: CLINICAL EFFICACY AND SAFETY OF SWITCHING ELTROMBOPAG AND RH-TPO IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA DURING THE COVID-19 PANDEMICX. Cai0X.-H. Zhang11 Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China1 Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, Chinahttp://journals.lww.com/10.1097/01.HS9.0000849468.68112.e2 |
| spellingShingle | X. Cai X.-H. Zhang P1653: CLINICAL EFFICACY AND SAFETY OF SWITCHING ELTROMBOPAG AND RH-TPO IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA DURING THE COVID-19 PANDEMIC HemaSphere |
| title | P1653: CLINICAL EFFICACY AND SAFETY OF SWITCHING ELTROMBOPAG AND RH-TPO IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA DURING THE COVID-19 PANDEMIC |
| title_full | P1653: CLINICAL EFFICACY AND SAFETY OF SWITCHING ELTROMBOPAG AND RH-TPO IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA DURING THE COVID-19 PANDEMIC |
| title_fullStr | P1653: CLINICAL EFFICACY AND SAFETY OF SWITCHING ELTROMBOPAG AND RH-TPO IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA DURING THE COVID-19 PANDEMIC |
| title_full_unstemmed | P1653: CLINICAL EFFICACY AND SAFETY OF SWITCHING ELTROMBOPAG AND RH-TPO IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA DURING THE COVID-19 PANDEMIC |
| title_short | P1653: CLINICAL EFFICACY AND SAFETY OF SWITCHING ELTROMBOPAG AND RH-TPO IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA DURING THE COVID-19 PANDEMIC |
| title_sort | p1653 clinical efficacy and safety of switching eltrombopag and rh tpo in patients with immune thrombocytopenia during the covid 19 pandemic |
| url | http://journals.lww.com/10.1097/01.HS9.0000849468.68112.e2 |
| work_keys_str_mv | AT xcai p1653clinicalefficacyandsafetyofswitchingeltrombopagandrhtpoinpatientswithimmunethrombocytopeniaduringthecovid19pandemic AT xhzhang p1653clinicalefficacyandsafetyofswitchingeltrombopagandrhtpoinpatientswithimmunethrombocytopeniaduringthecovid19pandemic |